| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $9.19M | $5.97M | $5.77M | $6.56M | $8.24M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $1.34B | -$94.68M | -$32.80M | $63.46M | -$144.84M |
| EPS (basic) | 105.3100 | -8.3600 | -3.0500 | 5.1900 | -10.7700 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |